Leadership Activation Recent leadership changes, including appointment of a new chairman and CEO, indicate a strategic shift and fresh decision-making that could accelerate partnerships, supplier agreements, and enterprise-scale collaborations in medical devices and thrombectomy technology.

Expansion Potential Plans to build a production plant in Sant Quirze del Vallès and ongoing product development suggest opportunities for contract manufacturing, supply chain partnerships, and regional distribution arrangements to support scale-up.

Clinical & Trials Active engagement in clinical development and the success of prior trials position the company for multi-site collaborations with hospitals, research centers, and contract research organizations to accelerate trials and regulatory milestones.

Strategic Funding Significant funding and investor backing, including a $39M raise and EU-backed partnerships, create a welcoming environment for strategic investors,OEM/medical device suppliers, and financing partners to support manufacturing, regulatory clearance, and commercialization.

Market Positioning Recognition as a leading anticipated medical device developer in Spain and participation in medtech events signals readiness for partnerships with distributors, regional pharma/healthcare networks, and hospital procurement teams seeking innovative thrombectomy solutions.